Harnessing the Medicaid Analytic eXtract (MAX) to Evaluate Medications in Pregnancy: Design Considerations

BACKGROUND: In the absence of clinical trial data, large post-marketing observational studies are essential to evaluate the safety and effectiveness of medications during pregnancy. We identified a cohort of pregnancies ending in live birth within the 2000–2007 Medicaid Analytic eXtract (MAX). Herei...

Descripción completa

Detalles Bibliográficos
Autores principales: Palmsten, Kristin, Huybrechts, Krista F., Mogun, Helen, Kowal, Mary K., Williams, Paige L., Michels, Karin B., Setoguchi, Soko, Hernández-Díaz, Sonia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693950/
https://www.ncbi.nlm.nih.gov/pubmed/23840692
http://dx.doi.org/10.1371/journal.pone.0067405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693950/
https://www.ncbi.nlm.nih.gov/pubmed/23840692
http://dx.doi.org/10.1371/journal.pone.0067405

Ejemplares similares